Transplantation’s leading luminaries and innovative thinkers will share inspiring research and insights at ATC 2026.
Nobel Prize-winning economist & author of Moral Economics: From Prostitution to Organ Sales, What Controversial Transactions Reveal About How Markets Work
Sunday, June 21 | 11 AM ET
Al Roth is the George Gund Professor of Economics and Business Administration in the Department of Economics at Harvard University, and in the Harvard Business School. His research, teaching, and consulting interests are in game theory, experimental economics, and market design. The best known of the markets he has designed (or, in this case, redesigned) is the National Resident Matching Program, through which approximately twenty thousand doctors a year find their first employment as residents at American hospitals.
He has recently been involved in the reorganization of the market for Gastroenterology fellows, which started using a clearinghouse in 2006 for positions beginning in 2007. He helped design the high school matching system used in New York City to match approximately ninety thousand students to high schools each year, starting with students entering high school in the Fall of 2004. He helped redesign the matching system used in Boston Public Schools, adopted for students starting school in September 2006. He is one of the founders and designers of the New England Program for Kidney Exchange, for incompatible patient-donor pairs. He is the chair of the American Economic Association's Ad Hoc Committee on the Job Market, which has designed a number of recent changes in the market for new Ph.D. economists. He is a Fellow of the American Academy of Arts and Sciences and the Econometric Society, and has been a Guggenheim and Sloan fellow. He received his Ph.D at Stanford University, and came to Harvard from the University of Pittsburgh, where he was the Andrew Mellon Professor of Economics.
Nobel Prize-winning physician-scientist & co-developer of life-saving mRNA vaccine technology
Tuesday, June 23 | 11 AM ET
Drew Weissman, MD, PhD, is the Roberts Family Professor in Vaccine Research and director of the Penn Institute for RNA Innovation at the Perelman School of Medicine. He is recognized for his work alongside Katalin Karikó in discovering the modified mRNA technology, which has launched a new era of vaccine and therapeutic development. Their mRNA research breakthrough has been used in both the BioNTech/Pfizer and Moderna COVID-19 vaccines and has revolutionized the field of vaccine development. Dr. Weissman's current research focuses on developing a pan-coronavirus vaccine to stop the next coronavirus epidemic, a universal flu vaccine, cancer therapeutics, a vaccine to prevent herpes, as well as developing in vivo gene therapy to allow worldwide use and a variety of protein therapeutics delivered with mRNA-LNPs. He has recently expanded his efforts in building scientific and medical equity and is developing the full RNA-LNP ecosystem of development, testing, and use in low and middle income countries.
Dr. Weissman earned bachelor's and master's degrees in biochemistry and enzymology from Brandeis University in 1981 and his M.D. and Ph.D. in immunology and microbiology in 1987 at Boston University School of Medicine. Following a residency at Beth Israel Hospital in Boston, he took a fellowship at the National Institutes of Health, where he worked with Dr. Anthony Fauci.
Dr. Weissman holds many patents and has published over 400 papers. He has been recognized with numerous awards including the Lasker-DeBakey Clinical Medical Research Award, the Breakthrough Prize in Life Sciences, the Albany Medical Center Prize in Medicine and Biomedical Research, and the Nobel Prize in Medicine or Physiology.